Contribution of FGF21 and macronutrient composition towards Glp1r agonist-induced weight loss
Description preview
Project Summary/ Abstract
Glucagon-like peptide-1 (Glp1) receptor (Glp1r) agonists are a promising new class of weight loss drugs for
treating obesity, yet weight loss outcomes to Glp1r agonists range from 0% to over 20% of starting body weight
which raises the critical question of why some individuals are more responsive than others. Previous…
Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click